Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Zirdu who wrote (5964)	1/26/1999 6:50:00 PM
From: mod	Read Replies (2) \| Respond to of 6136

There are onerous provisions ($60 million payment, 20% stock options) so I doubt there would be a higher bid. Has anyone else noticed that the "$60" bid is exactly 1/4 point above AGPH's 52-week high of 59 3/4? As if that is how they set the price. I wish they had demanded a better premium then $0.25 (unless they know something we don't and wanted to bail out, in which case I'll be happy with $60).

To: Zirdu who wrote (5964)	1/26/1999 7:48:00 PM
From: mod	Read Replies (1) \| Respond to of 6136

We're not the only ones who think the price is too low: Excerpt from Fortune's Street Life: By Andrew Serwer << HEAVY MERGER....Warner-Lambert is buying Agouron for $2.1 billion!!!!! Huh? Thought it would be worth more than that!!! >>